Stock comparison
Eli Lilly
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.27B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 77B | LMAT |
| Benjamin Graham | 86A | 89A | LMAT |
| Philip Fisher | 86A | 81C | LLY |
| Peter Lynch | 74B | 67B | LLY |
| Joel Greenblatt | 78C | 56D | LLY |
| Charlie Munger | 85A | 68D | LLY |
| Terry Smith | 77C | 69D | LLY |
Side-by-side metrics
| Metric | LLY | LMAT |
|---|---|---|
| Market cap | $1T | $2.27B |
| P/E (TTM) | 36.6x | 37.1x |
| EV/EBIT | 34.1x | 36.6x |
| ROIC (TTM) | 32.06% | 9.43% |
| Gross margin | 83.51% | 72.39% |
| Net margin | 34.98% | 24.35% |
| Revenue CAGR 5y | 23.17% | 12.75% |
| EPS CAGR 5y | 40.81% | 19.04% |
| Debt / Equity | 1.4x | 0.5x |
| Dividend yield | 0.62% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $2.27B+100%
- ROIC (TTM)32.06%vs 9.43%+71%
- EPS CAGR 5y40.81%vs 19.04%+53%
- Revenue CAGR 5y23.17%vs 12.75%+45%
LMAT leads on
- Debt / Equity0.5xvs 1.4x+66%
- Dividend yield0.84%vs 0.62%+25%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.